Acorda Therapeutics

Acorda cautiously steps forward with a drug to spur remyelination in MS
Fierce Biotech
Mon, 02/2/15 - 07:52 am
Acorda Therapeutics
MS
multiple sclerosis
remylination
rHIgM22
Biogen Idec's Critical Nerve Repair Drug is Poised for Big News -- Soon
TheStreet.com
Thu, 01/8/15 - 08:05 am
Biogen Idec
nerve repair
BIIB033
anti-LINGO-1
GSK
Vertex Pharmaceuticals
Acorda Therapeutics
3 Companies Growing Faster Than MannKind Corporation
Motley Fool
Wed, 12/17/14 - 08:13 am
MannKind
Alexion
Akorn
Acorda Therapeutics
Acorda posts 3Q revenue of $106 million, result beats expectations
Yahoo/AP
Thu, 10/30/14 - 12:15 pm
Acorda Therapeutics
earnings
Acorda Down on Plumiaz CRL
Yahoo/Zacks.com
Mon, 05/5/14 - 05:05 pm
Acorda Therapeutics
Plumiaz
epilepsy
Acorda Therapeutics says FDA rejects epilepsy drug
Yahoo/Reuters
Fri, 05/2/14 - 08:35 am
FDA
epilepsy
Acorda Therapeutics
Plumiaz
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
earnings
United Therapeutics
Celgene
Regeneron
Biogen Idec
Acorda Therapeutics
Amgen
Gilead Sciences
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
M&A
biotech
generics
Merck
Bristol-Myers Squibb
General Electric
Gilead Sciences
Thermo Fisher
Forest Labs
FDA
Acorda Therapeutics
Pfizer
JNJ
Roche
Pharmacyclics
Acorda Down on Q3 Earnings
Yahoo/Zacks
Mon, 11/4/13 - 09:59 am
earnings
Acorda Therapeutics
Acorda: A Biotech Company To Consider
Seeking Alpha
Sat, 04/13/13 - 11:44 am
Acorda Therapeutics
Acorda Therapeutics Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Wed, 02/13/13 - 11:02 am
Acorda Therapeutics
earnings
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Regeneron
Biogen Idec
Acorda Therapeutics
Sanofi
Celgene
Alexion
Biomarin
NPS Pharmaceuticals
Cerner
EXACT Sciences
Pfizer
Bristol-Myers Squibb
Eli Lilly
Potentially game changing data awaits Acorda in 2013
Reuters
Fri, 12/21/12 - 10:42 am
Acorda Therapeutics
AMPYRA
stroke
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tue, 09/4/12 - 11:08 am
Neurocrine Biosciences
Acorda Therapeutics
Amarin
Nektar
Acorda Therapeutics posts 2nd-quarter profit as sales and royalties from MS drug rise
Yahoo/AP
Tue, 07/31/12 - 01:26 pm
earnings
Acorda Therapeutics
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
Teva Pharmaceuticals
patents
Mylan
Momenta
Natco
Acorda Therapeutics
Copaxone
MS
multiple sclerosis
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 05:18 pm
Bacterin
Biomarin
Athersys
Affymax
Acorda Therapeutics
Alexion
Acorda Therapeutics To FDA: What Deadlines?
Pharmalot
Thu, 05/17/12 - 10:23 am
FDA
Acorda Therapeutics
adverse events
AMPYRA
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
BIO CEO Conference
Pfizer
Indenix
Keryx
Delcath
Oncothyreon
Acorda Therapeutics
Human Genome Sciences
Gilead

Pages